» Articles » PMID: 39571824

Prognostic Value of the 6-min Walk Test Derived Attributes in Patients with Idiopathic Pulmonary Fibrosis

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2024 Nov 21
PMID 39571824
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Idiopathic pulmonary fibrosis (IPF) is a fatal progressive fibrosing lung disease. A decreased 6-min walk distance (6MWD) and exercise-induced oxygen desaturation measured during the 6-min walk test (6MWT), are known predictors of mortality in patients with IPF. However, the use of antifibrotic drugs showed a survival benefit in IPF. Therefore, this study aimed to evaluate to what extend 6MWT-derived attributes are associated with two-year survival when antifibrotic drugs were introduced as part of standard IPF-care.

Methods: This real-world data-study included patients with IPF with a 6MWT between 2015 and 2020, and used composite outcome: mortality or lung transplantation within 2 years of follow-up. Data were collected systematically, including demographics, pulmonary function tests, comorbidities, medications and 6MWT-derived attributes. The prediction attributes of 6MWT were studied with a Cox Proportional-Hazards model and Kaplan-Meier survival curves. The best discriminating attribute to predict mortality was added to the prediction model Gender-Age-Physiology (GAP).

Results: In 216 patients, 2-year transplant-free survival cut-off points were identified for the 6MWD (≥413 m), 6MWD %predicted (≥83 %), SpO-nadir (≥86 %) and distance-saturation-product (≥374 m%), with the best discriminative value for SpO-nadir (area under the curve: 0.761). 2-Year survival percentage of patients with SpO-nadir below or above threshold (86 %) was 37.1 % and 80.0 %, respectively. Exercise-induced oxygen desaturation added to the GAP model showed an improvement in its predictive power.

Conclusion: Patients with IPF who have an exercise-induced oxygen desaturation have worse prognosis. Addition of SpO-nadir to the GAP model seems promising for use in clinical care of IPF patients.

Citing Articles

Prevalence and Predictors of Response to Antifibrotics in Long-Term Survivors with Idiopathic Pulmonary Fibrosis.

Cocconcelli E, Bernardinello N, Cameli P, Di Liberti R, Alhamad E, Gregori D Lung. 2025; 203(1):35.

PMID: 39998625 DOI: 10.1007/s00408-025-00789-4.